A tighter archive for life-science signals.
Search once, then narrow by source or topic.
AbbVie budgets $380M for obesity and neuroscience API facilities in Chicago
AbbVie budgets $380M for obesity and neuroscience API facilities in Chicago
Frontier, Harbour do licensing deals with GSK, Solstice
Frontier, Harbour do licensing deals with GSK, Solstice
A federal experiment opens up a new market for digital health — if it works
A federal experiment opens up a new market for digital health — if it works
Roche to stop work on bone health treatment for Duchenne
Roche to stop work on bone health treatment for Duchenne
Merck reorganizes; Blackstone to fund trials for J&J drug
Merck reorganizes; Blackstone to fund trials for J&J drug
First test of gene therapy for rare form of autism is underway
First test of gene therapy for rare form of autism is underway
Gilead to acquire cell therapy partner Arcellx for $7.8B
Gilead to acquire cell therapy partner Arcellx for $7.8B
Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
MoonLake has 'confidence' ahead of FDA submission, discloses mid-stage arthritis win
MoonLake has 'confidence' ahead of FDA submission, discloses mid-stage arthritis win
Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Vanda gets FDA approval for ‘franchise-extending’ antipsychotic
Vanda gets FDA approval for ‘franchise-extending’ antipsychotic
Grail's cancer test faces new uncertainty after UK study
Grail's cancer test faces new uncertainty after UK study
Ionis scraps Alzheimer’s drug for people with Down syndrome
Ionis scraps Alzheimer’s drug for people with Down syndrome
Supreme Court tariff ruling lets stand Trump’s authority to target pharma
Supreme Court tariff ruling lets stand Trump’s authority to target pharma
Candel prices offering, signs royalty deal; Calquence label expands
Candel prices offering, signs royalty deal; Calquence label expands
Daiichi taps John Tsai to lead R&D as Ken Takeshita departs
Daiichi taps John Tsai to lead R&D as Ken Takeshita departs
Novartis to divest India unit to private equity-led consortium for $159M
Novartis to divest India unit to private equity-led consortium for $159M
Sanofi appoints specialty care head; Biogen chair to retire in June
Sanofi appoints specialty care head; Biogen chair to retire in June
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page